Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (7)
  • 2025 (52)
  • 2024 (41)
  • 2023 (76)
  • 2022 (85)
  • 2021 (70)
  • 2020 (15)
  • 2019 (22)
  • 2018 (15)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4210)
  • Synthetic drugs (1141)
  • Guns/Weapons (1041)
  • OCDETF/Task Force (820)
  • Fake Pills (688)
  • Arrests/Convictions - Major (646)
  • Guilty Plea (559)
  • Seizures (Drugs/Property) (484)
  • Overdose (327)
  • Major Law Enforcement Operation (278)
  • Diversion Division (254)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (239)
  • Pharmaceuticals/Pharmacists/Physicians (228)
  • Money Laundering (218)
  • Gangs (202)
  • Outreach/Drug Prevention (189)
  • Fentanyl Awareness (167)
  • One Pill Can Kill (118)
  • HIDTA (105)
  • Press Conferences (69)
  • Narcoterrorism (55)
  • Prevention/Education - DEA websites GSAD, JTT etc (54)
  • Extraditions (52)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Fentanyl Free America (41)
  • Counterfeit Pills (39)
  • Asset Forfeiture (30)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Campaigns (14)
  • Terrorism (14)
  • Other (12)
  • Critical Incident (9)
  • Intergovernmental Affairs (9)
  • Cartel (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (372)
  • Congressional Affairs (15)

Drug Name

  • Oxycodone (77)
  • Fentanyl (57)
  • Opioids (57)
  • Synthetic Opioids (24)
  • Hydromorphone (21)
  • Methamphetamine (14)
  • Benzodiazepines (13)
  • Morphine (11)
  • Amphetamines (9)
  • Cocaine (9)
  • Heroin (8)
  • Methadone (5)
  • Marijuana (Cannabis) (3)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (45)
  • St. Louis (39)
  • New York (35)
  • Headquarters (34)
  • Seattle (25)
  • New England (24)
  • Atlanta (19)
  • Miami (19)
  • Chicago (16)
  • Dallas (15)
  • New Jersey (15)
  • El Paso (14)
  • Houston (13)
  • San Francisco (13)
  • Louisville (12)
  • Los Angeles (9)
  • Omaha (9)
  • New Orleans (8)
  • Phoenix (6)
  • Rocky Mountain (6)
  • San Diego (6)
  • Detroit (3)
  • Philadelphia (1)
Clear All Results
386 Results - Showing 371 to 380
PRESS RELEASE

Lasalle County Doctor Sentenced for Dispensing Prescription Drugs to Addicts for Sex

CHICAGO - A LaSalle County physician was sentenced today to 12 years in federal prison for illegally dispensing prescription medications, including opioids, in exchange for cash or sex. Constantino Perales, M.D., illegally prescribed oxycodone and Xanax to a patient, Andrew Strandell, knowing that Strandell would sell the pills on the...
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
PRESS RELEASE

Record settlement reached in University of Michigan hospital drug diversion civil penalty case

DETROIT - The Drug Enforcement Administration and United States Attorney’s Office for the Eastern District of Michigan today announced that the University of Michigan Health System has agreed to pay the United States $4.3 million as part of a settlement resolving allegations that UMHS violated certain provisions of the Controlled...
PRESS RELEASE

DEA investigators seeking answers in small Tennessee town

CELINA, Tenn. -- DEA investigators this week conducted inspections at several pharmacy locations in the Clay County, Tennessee town of Celina, following an inquiry into irregular patterns of pill purchases from drug distribution companies. DEA is now investigating possible criminal activity involving the illicit diversion of controlled prescription pharmaceuticals at...
PRESS RELEASE

Justice Department, DEA propose significant opioid manufacturing reduction in 2019

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...
PRESS RELEASE

Upper East Side doctor convicted in Brooklyn Federal Court of causing overdose death of a patient

BROOKLYN, N.Y. - A federal jury in Brooklyn today, following two weeks of trial, convicted Dr. Martin Tesher of 10 counts of unlawful distribution of oxycodone without legitimate medical purpose to five patients, one of whom died as a result two days after his last visit with the defendant. When...
PRESS RELEASE

Tampa doctor pleads guilty to distributing opioids outside DEA registration

TAMPA, Fla. – Jeffrey John Abraham (52, formerly of Tampa) has pleaded guilty to distributing controlled substances not specified in his Drug Enforcement Administration (DEA) registration. He faces a maximum penalty of four years’ imprisonment and a fine of up to $250,000. His sentencing date has not yet been set...
PRESS RELEASE

Department of Justice announces regulatory steps to address opioid epidemic

WASHINGTON – The Department of Justice today announced the finalization of an April proposal to improve the Drug Enforcement Administration’s ability to control the diversion of dangerous drugs in the midst of the national opioid crisis. Announced in April by Attorney General Jeff Sessions, the final rule sent for publication...
PRESS RELEASE

Senior Sinaloa Cartel leader extradited to the United States

WASHINGTON –Mexican authorities today extradited Sinaloa Cartel leader Damaso Lopez Nuñez, also known as “El Licenciado,” to the United States to face drug trafficking charges filed in the Eastern District of Virginia. Acting Assistant Attorney General John P. Cronan of the Justice Department’s Criminal Division; U.S. Attorney G. Zachary Terwilliger...
PRESS RELEASE

Attorney General Jeff Sessions Announces Uttam Dhillon as New Acting Administrator Of Drug Enforcement Administration

WASHINGTON – Today, Attorney General Jeff Sessions announced the appointment of Uttam Dhillon as Acting Administrator of the Drug Enforcement Administration. Dhillon will replace Robert Patterson, who has retired after 30 years of service. "With one American dying of a drug overdose every nine minutes, there can be no doubt...

Pagination

  • First page «
  • Previous
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Page 37
  • Current page 38
  • Page 39
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster